StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) operating KPIs

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)

Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%

Thermo Fisher Scientific mức thay đổi biên lợi nhuận phân khúc (Margin Expansion, điểm %) — Laboratory Products & Biopharma Services (%)

IR Financial Reconciliation Package

QuarterlyAnnual
Latest, Q3 2026
1.0%
Period ended Sep 30, 2026
Change on a year earlier
0.0 pts
1.0% in Q3 2025
History
15 quarters
Since Q1 2023
Sources
3
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMức thay đổi biên lợi nhuận phân khúc (Margin Expansion, điểm %) — Laboratory Products & Biopharma Services (%)Year on yearSource
Q3 2026Sep 30, 20261.0%0.0 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2026Jun 30, 20260.2%-0.7 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2026Mar 31, 2026-0.1%-0.1 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2025Dec 31, 20250.5%+0.5 ptsQ3 2026 Reconciliation of Financial Information ↗
Q3 2025Sep 30, 20251.0%+3.9 ptsQ3 2026 Reconciliation of Financial Information ↗
Q2 2025Jun 30, 20250.9%+2.1 ptsQ3 2026 Reconciliation of Financial Information ↗
Q1 2025Mar 31, 20250.0%+0.8 ptsQ3 2026 Reconciliation of Financial Information ↗
Q4 2024Dec 31, 20240.0%+0.1 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q3 2024Sep 30, 2024-2.9%-6.3 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q2 2024Jun 30, 2024-1.2%-2.8 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q1 2024Mar 31, 2024-0.8%-3.2 ptsQ4 & FY2025 Reconciliation of Financial Information ↗
Q4 2023Dec 31, 2023-0.1%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q3 2023Sep 30, 20233.4%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q2 2023Jun 30, 20231.6%–Q4 & FY2024 Reconciliation of Financial Information ↗
Q1 2023Mar 31, 20232.4%–Q4 & FY2024 Reconciliation of Financial Information ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Mức thay đổi biên lợi nhuận phân khúc (Margin Expansion, điểm %) — Laboratory Products & Biopharma Services (%), quarterly Q1 2023–Q3 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/seg_margin_chg_pt_lpbs

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.